HCWB
HCW Biologics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.52
-0.04 ▼ -7.69%
🌙 3월 13일 7:32 PM ET (한국 3/14 08:32)
$0.53
+0.01 ▲ +2.69%
| Index | - | P/E | - | EPS (ttm) | -13.96 | Insider Own | 17.84% | Shs Outstand | 0.01B | Perf Week | -16.77% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 81.64% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -47.88% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.84 | Inst Own | 7.93% | Short Float | 1.22% | Perf Quarter | -74.2% |
| Income | -0.02B | P/S | 7.07 | EPS this Y | 83.02% | Inst Trans | -26.37% | Short Ratio | 0.57 | Perf Half Y | -84.45% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 73.86% | ROA | -85.4% | Short Interest | 0.06M | Perf YTD | -46.83% |
| Book/sh | -0.8 | P/C | 2.7 | EPS past 3/5Y | -29.11% -29.55% | ROE | -27725.8% | 52W High | -97.1% ($17.80) | Perf Year | -96.14% |
| Cash/sh | 0.19 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 9.41% ($0.47) | Perf 3Y | -99.25% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 65.26% | Gross Margin | -351.39% | Volatility(W/M) | 15.55% 17.95% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 22.31 | Sales Y/Y TTM | -87.93% | Oper. Margin | -3157.1% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.06 | EPS Q/Q | 51.17% | Profit Margin | -5261.78% | RSI (14) | 30.44 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.06 | Sales Q/Q | -96.34% | SMA20 | -11.55% ($0.59) | Beta | 0.74 | Target Price | $2 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -44.48% ($0.94) | Rel Volume | 0.39 | Prev Close | $0.56 |
| Employees | 36 | LT Debt/Eq | - | EPS/Sales Surpr. | -361.39% -98.78% | SMA200 | -83.74% ($3.2) | Avg Volume(3M) | 0.10M | Price | $0.52 |
| IPO | 2021/7/20 | Option/Short | No/Yes | Trades | 1529 | Volume | 38,927 | Change | -7.69% |
뉴스 로딩 중...